Company intelligence / Profile preview

SynTheAll Pharmaceutical

Shanghai, Shanghai, Chinahuamedicine.com ↗

Ownership: Private
Employees: ~5000
Development stage: Commercial

Overview

SynTheAll provides process chemistry services and manufactures small-molecule advanced intermediates and APIs for use in preclinical/clinical trials as well as commercialized drugs. It has a pipeline of proprietary programs with some reaching NDA/BLA stage.

Therapeutic areas: PulmonologyOncologyOphthalmologyInfectious Diseases
Modalities: Small moleculeSynthetic oligonucleotidePeptides
Industry: Biotech

Partnerships

WuXi AppTec group partnership historicallyglobal pharma/biotech clients via CDMO business

Beyond the preview

Go deeper on SynTheAll Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SynTheAll Pharmaceutical.

Explore the full profile